EUVIMEDEUVIMED entdecken
Crossref

The control of autoimmunity by the microbiota-immune axis.

Andrey Kruglov

Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET · 01.01.2026

DOI: 10.17590/asr.0000440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET, erschienen am 01.01.2026. Verfasst von Andrey Kruglov.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the following study is to decipher the role of the microbiota in triggering autoimmune reactions. It is well known that diet influences the composition of the microbiota and the onset of autoimmune reactions. However, the molecular mechanisms underlying these processes are not yet fully understood. In this project, we will investigate how a high-glucose diet influences the composition of the microbiota and the development of autoimmune reactions. In particular, we will examine the role of cross-reactive antibodies in protecting the pancreas from the development of diabetes. We will further investigate the TLR4-lymphotxin axis in the induction of autoantibodies. Finally, we will investigate how a high-glucose diet influences T-cell development and what role lymphotoxin plays in this process. These experiments will enable us to understand the mechanism by which a high-glucose diet influences the microbiota and can lead to the development of autoimmune diseases. This knowledge will enable the development of strategies to modify the microbiota in order to prevent autoimmune reactions and thus protect people from the development of autoimmunity. In particular, the results generated will lead to antibody prototypes and bacterial strains capable of inhibiting type 2 diabetes and associated metabolic disorders. Such antibodies can also be used to treat metabolic disorders. In addition, supplementing patients with probiotic strains and developing diets that promote the growth of these bacteria will be key strategies for further improving the course of the disease.

Schlagwörter

autoimmunitygut microbiotamicrobiota-immune axishigh-glucose diettype 2 diabetescross-reactive antibodiesautoantibodiesTLR4lymphotoxinT cell development

Zitieren

APA

Kruglov, A. (2026). The control of autoimmunity by the microbiota-immune axis. Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET. https://doi.org/10.17590/asr.0000440

Vancouver

Kruglov A. The control of autoimmunity by the microbiota-immune axis. Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET. 2026. doi:10.17590/asr.0000440

BibTeX
@article{Kruglov2026,
  author = {Kruglov, Andrey},
  title = {The control of autoimmunity by the microbiota-immune axis},
  journal = {Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET},
  year = {2026},
  doi = {10.17590/asr.0000440}
}
Kostenlos starten →